Management Team

Anders Rylander
Anders RylanderCEO since 2010
Anders Rylander has an MSc in Mechanical Engineering with specialties in Industrial Economics and Management from the Swedish Royal Institute of Technology. He has been a management consultant for more than 15 years, at companies such as Accenture and Andersen Consulting. Anders co-founded Axholmen, a management consulting firm that focuses on improving the operational efficiency of large corporations in the Nordic market. He also founded Arinvest, a private equity investment firm investing in the clean-tech and life science business areas.
Holdings: 3 575 640 A-shares, 368 956 B-shares, 20 000 warrants 2019/2022 (TO5)
Cecilia Driving
Cecilia DrivingEVP CFO since 2016
Education / background: Cecilia Driving has a law degree. bachelor’s and a bachelor’s degree in economics from Stockholm University. Cecilia Driving has experience from life science, IT, telecom and the research industry as CFO / CFO and in-house lawyer. She has experience from stock exchanges, private equity, owner-managed and state-owned companies.
Ongoing assignments: Cecilia Driving is a board member of Ovzon AB and chairman of the board of Adom AB.

Holding in the company: Cecilia Driving owns 20,000 B shares, 20,000 warrants 2018/2021 (TO3)

OTTI BENGTSSON GREF (1968)VP R&D from 2020
Education / background: Otti is a medical licentiate in immunology from Uppsala University and has an executive MBA from MGruppen. She has more than 20 years of experience in research and product development and production from academia and industry. She has held several management positions in both development and production at Thermo Fischer and has extensive experience in product development of in vitro diagnostic tests. Most recently, Otti came from Cavidi, which develops, produces and markets molecular diagnostics in the field of HIV, where she was Director of Research and Development.
Holdings in the company: 20,000 warrants 2019/2022 (TO5)
HENRIK WINTHER (1966)SVP Business Development since 2020
Education/background: Henrik was Associate Professor in Anatomy, Physiology and Cell Biology at University of
prior to taking employment at the diagnostics company, Dako, which was later acquired by Agilent. Henrik held
several executive management positions at Dako. He was the R&D Director prior to taking over as Business Area Manager
for Companion Diagnostics. Under his management, the business area experienced tenfold growth in both revenue and number
of employees. At Agilent, Henrik was appointed Vice President and General Manager of the Companion Diagnostics
to his employment at Biovica, Henrik worked at SVP Business Development at the Swedish diagnostics company,
Current assignments: Board member at SAGA Diagnostics AB.
Holding in the company: 40,000 warrants
ROBERT DANN (1962)SVP Marketing since 2020
Education / Background: Robert Dann holds a Master’s degree in Russian Civilization from the University of Chicago and an MBA from Columbia University. He has over 20 years of experience in the health industry, in roles that span the country manager, global product launches and strategy formulation. He has worked in cancer care, medicine, diagnostics and artificial intelligence at AstraZeneca, GE Healthcare and IBM Watson Health. Robert has contributed to bringing a number of groundbreaking products to market in the healthcare field.

Holding: 20,000 B shares

TOMAS ANDERSSON (1960)VP Operations from 2020
Education/background: Tomas has a University Certificate in Medical Laboratory Technology and experience from more than 30 years in the Life Science business. His experience ranges from production and logistics to process development, new product introduction and QC/QA. He has had managerial positions in Biacore, GE Healthcare and Doxa for the past 20 years. Tomas’ most recent position is at Olink Proteomics, a protein biomarker discovery company, managing 50-100% volume growth for five consecutive years whilst introducing 2-3 new products per year as head of Supply Chain.
Holdings: –
HELLE FISKER (1969)VP Commercial from 2021
Education / background: Helle Fisker holds an MSc in Biotech Engineering with a specialty in Immunology from the Technical University of Denmark and an Executive MBA from Copenhagen Business School. For the past 20 years, she has worked in sales and marketing roles for oncology and cancer diagnostic companies and executed multiple global product launches and Go to Market commercial strategies for companies GSK, Dako (now Agilent), Leica Biosystems, and taken new products to the European markets for SME ViroGates and Visiopharm. Before joining Biovica, Helle Fisker worked as a strategy and market consultant for companies, i.e., Sysmex, Diaceutics, Tieto, and Pathcore, working with advanced, core, genetic, and digital cancer diagnostics, and oncology.
Holdings in the company: none
Joakim Arwidson
Joakim ArwidsonVP RA/QA since 2021
Education / background: Joakim has a bachelor’s degree in computer and electronics, Linköping Institute of Technology (LiTH) at Linköping University. He has more than 25 years of experience in life science with QA/RA experience from development, production, surveillance, market introductions in North America, Europe and Asia. Joakim has worked in bone densitometry, fluoroscopy and C-arms. For the past 10 years, he has held the position of VP Quality and Regulatory at Hermes Medical Solutions in molecular imaging with a focus on post processing in oncology and theranostics.
Holdings in the company: none
WARREN CRESSWELL (1968)President Americas since 2021
Education/background: M.B.A. from University of Pittsburgh and B.A. in Chemistry from California State University, Northridge. Warren has over 25 years of experience in the diagnostics industry. He was previously CEO at Prometheus Labs, CEO at Microbiome Diagnostic Partners and Vice President at Dako leading the Asia Pacific Business Unit.
Current assignments: Board member at Demeter Sciences.
Holdings: none